Arkolith/Insider Trading/ACAD/Form 4

Rhodes Jennifer J

EVP, CHIEF LEGAL OFFICER, SECACADIA PHARMACEUTICALS INC (ACAD) · full profile →Form 4 · filed Feb 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$162K
Net Open-Market Flow
-$162K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 9, 2026Sell(S)7K$23.38$162K8K
Feb 6, 2026Option exercise(M)13K—$015K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 6, 2026Option exercise(M)13K—$013K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001568249-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML